Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.
Shen, C.H., Wang, Y.F., Kovalevsky, A.Y., Harrison, R.W., Weber, I.T.(2010) FEBS J 277: 3699-3714
- PubMed: 20695887 
- DOI: 10.1111/j.1742-4658.2010.07771.x
- Primary Citation of Related Structures:  
3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO - PubMed Abstract: 
The structural and kinetic effects of amprenavir (APV), a clinical HIV protease (PR) inhibitor, were analyzed with wild-type enzyme and mutants with single substitutions of V32I, I50V, I54V, I54M, I84V and L90M that are common in drug resistance. Crystal structures of the APV complexes at resolutions of 1 ...